Universal Vision Valuation Multiples

Universal Vision Overview

About Universal Vision

Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of sales of optical devices, glasses, lenses, and other vision aid products; optometric services; sales and leasing of medical devices; and providing hospital management and technical consultancy services. The company's reportable segments include its Ophthalmology Business segment and the Optometry Business segment. A majority of its revenue is generated from the Ophthalmology Business segment, which is responsible for providing ophthalmic clinics and hospital technical services and consultancy services, and leasing services. The Optometry Business segment is responsible for the sales of glasses and peripheral equipment. Geographically, the company derives maximum revenue from Taiwan and the rest from China.

Founded

1994

HQ

Employees

325

Website

uvb.com.tw

Sectors

Medical DevicesMedical SuppliesDeepTechHealthTech

Financials (LTM)

Revenue: $132M

EBITDA: $59M

EV

$323M

Valuation Multiples

Multiples.vc

Start free trial

Universal Vision Financials

Universal Vision reported last 12-month revenue of $132M and EBITDA of $59M.

In the same LTM period, Universal Vision generated $59M in EBITDA and $33M in net income.

Universal Vision P&L

In the most recent fiscal year, Universal Vision reported revenue of $134M and EBITDA of $61M.

Universal Vision expects next 12-month revenue of XXX and NTM EBITDA of XXX

Universal Vision Stock Performance

Universal Vision has current market cap of $356M, and enterprise value of $323M.

Universal Vision's stock price is $4.20.

Universal Vision Valuation Multiples

Universal Vision trades at 2.4x EV/Revenue multiple, and 5.5x EV/EBITDA.

Universal Vision Financial Valuation Multiples

As of April 19, 2026, Universal Vision has market cap of $356M and EV of $323M.

Equity research analysts estimate Universal Vision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Universal Vision has a P/E ratio of 10.7x.

Universal Vision Margins & Growth Rates

Universal Vision's revenue in the last 12 month grew by 3%.

Universal Vision's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Universal Vision's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Universal Vision's rule of X is 48% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Universal Vision Public Comps

See public comps and valuation multiples for other Medical Devices and Medical Supplies comps.

Universal Vision M&A Activity

Universal Vision acquired XXX companies to date.

Last acquisition by Universal Vision was on XXXXXXXX, XXXXX. Universal Vision acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Universal Vision Investment Activity

Universal Vision invested in XXX companies to date.

Universal Vision made its latest investment on XXXXXXXX, XXXXX. Universal Vision invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).